Skip to main content
SpringerLink
Log in

Prediction of Non-Linear Pharmacokinetics of Monoclonal Antibodies in Human from Nonclinical Data: Are We There Yet?

  • Commentary
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

The Original Article was published on 13 June 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mullard A. FDA approves 100th monoclonal antibody product. Nat Rev Drug Discov. 2021. https://doi.org/10.1038/d41573-021-00079-7.

    Article  PubMed  Google Scholar 

  2. Li GF, Zheng QS, Yu Y, et al. Impact of ethnicity-specific hepatic microsomal scaling factor, liver weight, and cytochrome P450 (CYP) 1A2 content on physiologically based prediction of CYP1A2-mediated pharmacokinetics in young and elderly Chinese adults. Clin Pharmacokinet. 2019;58(7):927–41.

    Article  Google Scholar 

  3. Mahmood I. Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation. J Pharm Sci. 2009;98(10):3850–61.

    Article  CAS  Google Scholar 

  4. Oitate M, Nakayama S, Ito T, Kurihara A, Okudaira N, Izumi T. Prediction of human plasma concentration–time profiles of monoclonal antibodies from monkey data by species-invariant time method. Drug Metab Pharmacokinet. 2012;27(3):354–9.

    Article  CAS  Google Scholar 

  5. Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2012;39(1):67–86.

    Article  CAS  Google Scholar 

  6. Luu KT, Bergquist S, Chen E, Hu-Lowe D, Kraynove E. A model-based approach to predicting the human pharmacokinetics of a monoclonal antibody exhibiting target-mediated drug disposition. J Pharmacol Exp Ther. 2012;341(3):702–8.

    Article  CAS  Google Scholar 

  7. Wang W, Prueksaritanont T. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Biopharm Drug Dispos. 2010;31(4):253–63.

    PubMed  Google Scholar 

  8. Singh R, Moreno M, Stanimirovic D. Comparison of various approaches to translate non-linear pharmacokinetics of monoclonal antibodies from cynomolgus monkey to human. Eur J Drug Metab Pharmacokinet. 2021. https://doi.org/10.1007/s13318-021-00691-3.

    Article  PubMed  Google Scholar 

  9. Wang J, Iyer S, Fielder PJ, Davis JD, Deng R. Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development. Biopharm Drug Dispos. 2016;37(2):51–65.

    Article  Google Scholar 

  10. Glassman PM, Balthasar JP. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies. J Pharmacokinet Phar. 2016;43(4):427–46.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, University of Florida, Gainesville, FL, USA

    Yichao Yu

  2. College of Pharmacy, Dalian Medical University, Dalian, China

    Qi-Qi Zhao

  3. College of Clinical Medicine, Yangzhou University, Yangzhou, 225009, China

    Qi-Qi Zhao & Guo-Fu Li

Authors
  1. Yichao Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi-Qi Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guo-Fu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guo-Fu Li.

Ethics declarations

Funding

This work was not funded or supported by any organization.

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Code Availability

Not applicable.

Availability of Data and Material

Not applicable.

Author Contributions

Conceptualization: GFL. Drafting of the manuscript: YY. Critical revision of the manuscript: GFL. Drafting and modifying of the figure: YY, GFL, and QQZ. Supervision: GFL.

Additional information

This comment refers to the article available at https://doi.org/10.1007/s13318-021-00691-3.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, Y., Zhao, QQ. & Li, GF. Prediction of Non-Linear Pharmacokinetics of Monoclonal Antibodies in Human from Nonclinical Data: Are We There Yet?. Eur J Drug Metab Pharmacokinet 46, 569–571 (2021). https://doi.org/10.1007/s13318-021-00702-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-021-00702-3

Search

Navigation